 PDAO is to Revolutionize Decentralized Autonomous Organization DAO AGOURA HILLS, Calif., Jan. 17, 2023 GLOBE NEWSWIRE Oncotelic Therapeutics, Inc OTCQB:OTLC Oncotelic, the Company or We, a clinical stage biotechnology company, with a planned IPO of its JV this year, today announced the launch of Pet2DAO Inc. Pet2Dao, a wholly owned subsidiary of Oncotelic,... The post Oncotelic Announces the launch of PDAO token appeared first on DKODING... 